A pharmaceutical breakthrough was unveiled by the Emirates Drug Establishment (EDE) on Thursday, April 23, with the announcement of the UAE’s first fully AI-discovered and developed drug candidate by a research team at Insilico Medicine in Masdar City, Abu Dhabi.
The candidate, known as ISM0387, is a drug that targets an enzyme called PRMT5. It employs a method called “synthetic lethality” which enhances its selective activity against cancer cells while minimising its impact on healthy cells.
